6ix — Find Your Next Investment

Discover investor relations events, company profiles, and investment opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

About

Moleculin Biotech Inc (NASDAQ:MBRX) — investor relations, events, news, and company updates on 6ix.

Latest News

Moleculin Releases Next CEO Corner Segment Highlighting Annamycin’s Non-Cardiotoxic Profile

Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout

Moleculin Reports Full Year 2025 Financial Results and Confirms Highly Anticipated 45-Patient Interim Data Unblinding in Pivotal MIRACLE Trial On Track for Mid-2026

Moleculin to Present at 38th Annual ROTH Conference

Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study

Financials

Revenue

$0

Market Cap

$13.61 M

EPS

-28.42

Community Chat

Ask AI